These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15164073)

  • 1. Oncogenomics and the development of new cancer therapies.
    Strausberg RL; Simpson AJ; Old LJ; Riggins GJ
    Nature; 2004 May; 429(6990):469-74. PubMed ID: 15164073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenomics: prospects for the future.
    Sakatani T; Onyango P
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):891-901. PubMed ID: 14686710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical and legal aspects of oncogenomics.
    Stankov K; Draskovic D; Mikov M
    J BUON; 2012; 17(2):383-8. PubMed ID: 22740222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Informatics: New Tools for a Data-Driven Age in Cancer Research.
    Kibbe W; Klemm J; Quackenbush J
    Cancer Res; 2017 Nov; 77(21):e1-e2. PubMed ID: 29092926
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncogenomics 2005 meeting report: dissecting cancer through genome research.
    Feigal EG; Dracopoli NC; Trent JM
    Cancer Res; 2005 Oct; 65(19):8587-90. PubMed ID: 16204021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenomics.
    Gomase VS; Tagore S; Kale KV; Bhiwgade DA
    Curr Drug Metab; 2008 Mar; 9(3):199-206. PubMed ID: 18336222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Normal' genes key to cancer growth.
    Check Hayden E
    Nature; 2008 Feb; 451(7179):615. PubMed ID: 18256629
    [No Abstract]   [Full Text] [Related]  

  • 8. A compendium of mutational cancer driver genes.
    Martínez-Jiménez F; Muiños F; Sentís I; Deu-Pons J; Reyes-Salazar I; Arnedo-Pac C; Mularoni L; Pich O; Bonet J; Kranas H; Gonzalez-Perez A; Lopez-Bigas N
    Nat Rev Cancer; 2020 Oct; 20(10):555-572. PubMed ID: 32778778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging clinical relevance of genomics in cancer medicine.
    Berger MF; Mardis ER
    Nat Rev Clin Oncol; 2018 Jun; 15(6):353-365. PubMed ID: 29599476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenomics 2005--Dissecting Cancer through Genome Research. 2-6 February 2005, San Diego, CA, USA.
    Pusztai L
    IDrugs; 2005 Mar; 8(3):215-8. PubMed ID: 15772892
    [No Abstract]   [Full Text] [Related]  

  • 11. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating genomics for precision cancer medicine.
    Roychowdhury S; Chinnaiyan AM
    Annu Rev Genomics Hum Genet; 2014; 15():395-415. PubMed ID: 25184532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Big data in biomedicine.
    Bender E
    Nature; 2015 Nov; 527(7576):S1. PubMed ID: 26536215
    [No Abstract]   [Full Text] [Related]  

  • 14. From oncogene to network addiction: the new frontier of cancer genomics and therapeutics.
    Tonon G
    Future Oncol; 2008 Aug; 4(4):569-77. PubMed ID: 18684067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCG: an integrative resource of cancer protein-coding genes and long noncoding RNAs.
    Liu M; Yang YT; Xu G; Tan C; Lu ZJ
    Discov Med; 2016 Dec; 22(123):351-359. PubMed ID: 28147217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes expand during evolution to withstand somatic amplification.
    Wang X; Li X; Zhang L; Wong SH; Wang MHT; Tse G; Dai RZW; Nakatsu G; Coker OO; Chen Z; Ko H; Chan JYK; Liu T; Cheng CHK; Cheng ASL; To KF; Plewczynski D; Sung JJY; Yu J; Gin T; Chan MTV; Wu WKK
    Ann Oncol; 2018 Nov; 29(11):2254-2260. PubMed ID: 30204835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
    Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
    Gene; 2019 May; 697():57-66. PubMed ID: 30796966
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.